BRL 37344 [Ligand Id: 567] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL284782 (BRL-37344)
  • β1-adrenoceptor/Beta-1 adrenergic receptor in Human [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
  • β1-adrenoceptor/Beta-1 adrenergic receptor in Rat [ChEMBL: CHEMBL3252] [GtoPdb: 28] [UniProtKB: P18090]
There should be some charts here, you may need to enable JavaScript!
  • β2-adrenoceptor/Beta-2 adrenergic receptor in Human [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
  • Beta-2 adrenergic receptor in Dog [ChEMBL: CHEMBL2289] [UniProtKB: P54833]
  • β2-adrenoceptor/Beta-2 adrenergic receptor in Rat [ChEMBL: CHEMBL3754] [GtoPdb: 29] [UniProtKB: P10608]
There should be some charts here, you may need to enable JavaScript!
  • β3-adrenoceptor/Beta-3 adrenergic receptor in Human [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
  • β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
  • β3-adrenoceptor/Beta-3 adrenergic receptor in Rat [ChEMBL: CHEMBL4031] [GtoPdb: 30] [UniProtKB: P26255]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
ChEMBL Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand. B 4.95 pKi 11300 nM Ki Bioorg Med Chem Lett (1996) 6: 2253-2258
GtoPdb - - 5.2 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
ChEMBL Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells B 5.95 pKi 1130 nM Ki Bioorg Med Chem Lett (1997) 7: 1583-1588
ChEMBL Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol B 5.3 pIC50 5000 nM IC50 Bioorg Med Chem Lett (1998) 8: 3087-3092 [PMID:9873681]
ChEMBL Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR F 5.77 pEC50 1700 nM EC50 Bioorg Med Chem Lett (2003) 13: 1301-1305 [PMID:12657269]
ChEMBL Agonist activity at Homo sapiens (human) beta1 adrenoreceptor B 5.77 pEC50 1700 nM EC50 Med Chem Res (2010) 19: 1121-1140 [PMID:21170122]
GtoPdb - - 6.5 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
β1-adrenoceptor/Beta-1 adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3252] [GtoPdb: 28] [UniProtKB: P18090]
ChEMBL Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol B 5.48 pIC50 3300 nM IC50 J Med Chem (1992) 35: 3081-3084 [PMID:1354264]
ChEMBL In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle F 6.72 pIC50 190 nM IC50 J Med Chem (1992) 35: 3081-3084 [PMID:1354264]
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
ChEMBL Displacement of [125I]CYP from human adrenergic beta 2 receptor transfected in CHO cells in presence of 100 uM GTP B 5.55 pKi 2850 nM Ki Bioorg Med Chem (2007) 15: 2533-2543 [PMID:17303428]
ChEMBL Ability to bind to human Beta-2 adrenergic receptor using membranes of stably transfected CHO cells B 6.2 pKi 630 nM Ki Bioorg Med Chem Lett (1997) 7: 1583-1588
ChEMBL Compound was tested for its binding affinity against beta2 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand. B 6.2 pKi 630 nM Ki Bioorg Med Chem Lett (1996) 6: 2253-2258
GtoPdb - - 6.5 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
ChEMBL Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol B 5.52 pIC50 3000 nM IC50 Bioorg Med Chem Lett (1998) 8: 3087-3092 [PMID:9873681]
ChEMBL Agonistic activity against human Beta-2 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR F 6.54 pEC50 290 nM EC50 Bioorg Med Chem Lett (2003) 13: 1301-1305 [PMID:12657269]
ChEMBL Agonist activity at Homo sapiens (human) beta2 adrenoreceptor F 6.54 pEC50 290 nM EC50 Med Chem Res (2010) 19: 1121-1140 [PMID:21170122]
GtoPdb - - 6.9 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
Beta-2 adrenergic receptor in Dog (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2289] [UniProtKB: P54833]
ChEMBL Agonistic activity for Beta-2 adrenergic receptor was assessed by it's inhibitory effect on spontaneous contractions in isolated rat uterus F 8.04 pIC50 9.12 nM IC50 J Med Chem (2003) 46: 105-112 [PMID:12502364]
β2-adrenoceptor/Beta-2 adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3754] [GtoPdb: 29] [UniProtKB: P10608]
ChEMBL Compound was evaluated for its binding affinity towards Beta-2 adrenergic receptor in rat soleus membrane by displacing (-)-isoproterenol (50 uM) B 5.89 pIC50 1300 nM IC50 J Med Chem (1992) 35: 3081-3084 [PMID:1354264]
ChEMBL Agonistic activity towards beta-2 adrenoceptor. Mean concentration required to produce 50% inhibition of uterine contraction F 8.04 pIC50 9.12 nM IC50 J Med Chem (2001) 44: 1436-1445 [PMID:11311067]
ChEMBL Inhibition of spontaneous contractions in isolated rat uterus F 8.04 pIC50 9.1 nM IC50 J Med Chem (2003) 46: 105-112 [PMID:12502364]
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
ChEMBL Ability to bind to human Beta-3 adrenergic receptor using membranes of stably transfected CHO cells B 6.02 pKi 960 nM Ki Bioorg Med Chem Lett (1997) 7: 1583-1588
ChEMBL Compound was tested for its binding affinity against beta3 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand. B 6.02 pKi 960 nM Ki Bioorg Med Chem Lett (1996) 6: 2253-2258
ChEMBL Binding affinity against CHO cells transfected with human beta-3 adrenergic receptor in the presence of [125I]iodocyanopindolol B 6.18 pKi 660 nM Ki Bioorg Med Chem Lett (2001) 11: 3035-3039 [PMID:11714605]
GtoPdb - - 7 pKi 100 nM Ki Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421];
Mol Pharmacol (1993) 44: 1094-104 [PMID:7903415];
J Pharmacol Exp Ther (1994) 269: 1000-6 [PMID:7912272];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417]
ChEMBL Effective concentration for stimulation of adenylyl cyclase activity in CHO-beta3 AR expressing cell membranes F 6.17 pEC50 680 nM EC50 Bioorg Med Chem Lett (1997) 7: 1583-1588
ChEMBL Compound was tested for its ability to stimulate adenylyl cyclase activity in CHO-beta-3 adrenergic receptor cell membrane. F 6.17 pEC50 680 nM EC50 Bioorg Med Chem Lett (1996) 6: 2253-2258
ChEMBL Compound was evaluated for agonistic activity in human Beta-3 adrenergic receptor assay; partial weak agonist F 6.35 pEC50 450 nM EC50 Bioorg Med Chem Lett (1998) 8: 3087-3092 [PMID:9873681]
ChEMBL Agonism against Beta-3 adrenergic receptor F 6.35 pEC50 450 nM EC50 Bioorg Med Chem Lett (1998) 8: 3087-3092 [PMID:9873681]
GtoPdb - - 7.5 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
ChEMBL Agonist activity at Homo sapiens (human) beta3 adrenoreceptor B 7.68 pEC50 21 nM EC50 Med Chem Res (2010) 19: 1121-1140 [PMID:21170122]
ChEMBL Agonism of recombinant human beta-3 adrenergic receptor assayed by measuring cAMP accumulation in CHO cells expressing beta3-AR F 7.68 pEC50 21 nM EC50 Bioorg Med Chem Lett (2003) 13: 1301-1305 [PMID:12657269]
ChEMBL Agonist activity at human adrenergic beta3 receptor expressed in CHO cells assessed as [3H]cAMP levels by radiolabeled ligand based assay F 8.23 pEC50 5.9 nM EC50 Bioorg Med Chem (2008) 16: 2473-2488 [PMID:18083578]
ChEMBL Concentration required to effect a 50% relaxation of ferret detrusor basal tone F 8.66 pEC50 2.2 nM EC50 J Med Chem (2003) 46: 105-112 [PMID:12502364]
ChEMBL Agonistic activity for Beta-3 adrenergic receptor as relaxing ability of isolated ferret detrusor basal tone F 8.66 pEC50 2.19 nM EC50 J Med Chem (2003) 46: 105-112 [PMID:12502364]
ChEMBL Agonist activity at human adrenergic beta-3 receptor expressed in CHO cells assessed as cAMP levels by DELFIA method F 8.96 pEC50 1.1 nM EC50 Bioorg Med Chem (2008) 16: 2473-2488 [PMID:18083578]
ChEMBL Agonistic activity against human Beta-3 adrenergic receptor as cAMP accumulation in CHO cells expressing beta3-AR F 10.02 pEC50 0.1 nM EC50 Bioorg Med Chem Lett (2003) 13: 1301-1305 [PMID:12657269]
β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
GtoPdb - - 6.5 pKi - - - Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421]
β3-adrenoceptor/Beta-3 adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4031] [GtoPdb: 30] [UniProtKB: P26255]
GtoPdb - - 6.5 pKi - - - Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421]
ChEMBL In vitro beta-adrenergic activity against beta-3 adrenergic receptor in rat epididymal fat pads by stimulation of glycerol release from adipocytes. F 8.08 pEC50 8.4 nM EC50 J Med Chem (1992) 35: 3081-3084 [PMID:1354264]
ChEMBL Agonistic activity towards beta-3 adrenoceptor. Mean concentration required to produce 50% relaxation of detrusor before the addition in the ferret detrusor F 8.66 pEC50 2.19 nM EC50 J Med Chem (2001) 44: 1436-1445 [PMID:11311067]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]